TME Pharma

TME Pharma's Ordinary Shares

• Date of the IPO: September 28, 2016
• ISIN / Mnemo : NL0015000YE1 / ALTME
• Stock exchange: Euronext Growth Paris
• Fiscal year end : December 31
• Number of shares (September 27, 2024): 42,185,311*
• Liquidity contract: Invest Securities

*Taking into account the shares issuance following the exercise of Warrants Z as published on September 27, 2024.


TME Pharma's Warrants Z

• ISIN NL0015001SR3
• Stock exchange: Euronext Growth Paris
• Number of Warrants Z (September 27, 2024): 2,811,080

 

Rapid access to French brokers

        

Aram Mangasarian, CEO:

"We have received and taken note of the letter received from a shareholder group claiming 18% of TME shares referred to in the Boursier.com article of October 31st, 2024 (link). We thank the investors for thinking along with management and can confirm, as disclosed most recently in the 2024 half-year report, that management are actively pursuing multiple types of transactions for our lead asset, NOX-A12."
"Nous avons reçu et pris note de la lettre d'un groupe d'actionnaires revendiquant 18% des actions de TME, mentionnée dans l'article de Boursier.com du 31 octobre 2024 (lien). Nous remercions les investisseurs d'avoir réfléchi avec la direction et nous pouvons confirmer, comme indiqué récemment dans le rapport semestriel 2024, que la direction poursuit activement plusieurs types de transactions pour notre actif principal, NOX-A12."

Analyst Coverage

Firm  Analyst  latest Reports (more) 
Invest Securities   Jamila El Bougrini, PhD 2024, July 18 (EN/FR)
2024, June 27 (EN/FR)
2024, June 19 (EN/FR)
In Extenso   Jean-Pierre Loza, PhD  2024, October 29 (EN/FR)
2023, November 06 (EN/FR)
2023, September 25 (EN/FR)
 
TME Pharma N.V. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding TME Pharma’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of TME Pharma or its management. TME Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

 

   

 

We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (Google Analytics cookies). You can decide for yourself whether you want to accept the cookies. Please note that if you refuse cookies, you may no longer be able to use all of the site's functions.